Legacy Capital Group California, Inc. Ironwood Pharmaceuticals Inc Transaction History
Legacy Capital Group California, Inc.
- $328 Billion
- Q4 2024
A detailed history of Legacy Capital Group California, Inc. transactions in Ironwood Pharmaceuticals Inc stock. As of the latest transaction made, Legacy Capital Group California, Inc. holds 18,569 shares of IRWD stock, worth $31,567. This represents 0.03% of its overall portfolio holdings.
Number of Shares
18,569
Previous 14,307
29.79%
Holding current value
$31,567
Previous $58.9 Million
39.55%
% of portfolio
0.03%
Previous 0.02%
Shares
2 transactions
Others Institutions Holding IRWD
# of Institutions
235Shares Held
162MCall Options Held
11.2MPut Options Held
9.1K-
Black Rock Inc. New York, NY22.9MShares$38.9 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA22MShares$37.5 Million0.0% of portfolio
-
Sarissa Capital Management LP Greenwich, CT16.4MShares$27.9 Million16.75% of portfolio
-
Pacer Advisors, Inc. Malvern, PA11.7MShares$19.9 Million0.13% of portfolio
-
State Street Corp Boston, MA9.92MShares$16.9 Million0.0% of portfolio
About IRONWOOD PHARMACEUTICALS INC
- Ticker IRWD
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 153,231,008
- Market Cap $260M
- Description
- Ironwood Pharmaceuticals, Inc., a healthcare company, focuses on the development and commercialization of gastrointestinal (GI) products. It markets linaclotide, a guanylate cyclase type-C agonist for the treatment of adults suffering from irritable bowel syndrome with constipation (IBS-C) or chronic idiopathic constipation (CIC) under the LINZE...